SeaStar Medical Holding Corporation - Common Stock (ICU)
0.4051
-0.0148 (-3.52%)
NASDAQ · Last Trade: Jun 28th, 1:22 AM EDT
Detailed Quote
Previous Close
0.4199
Open
0.4199
Bid
0.4000
Ask
0.4200
Day's Range
0.4000 - 0.4475
52 Week Range
0.3054 - 13.85
Volume
2,915,962
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
14,497,655
Chart
About SeaStar Medical Holding Corporation - Common Stock (ICU)
SeaStar Medical Holding Corporation is a biotechnology company focused on developing innovative therapies to enhance the treatment of life-threatening kidney conditions. The company is primarily engaged in researching and creating advanced medical devices and technologies designed to improve the care of patients with acute kidney injury and other renal-related disorders. By leveraging its proprietary approach, SeaStar Medical aims to provide solutions that reduce the need for dialysis and improve patient outcomes, ultimately transforming the standard of care in nephrology. Read More
DETROIT, MICHIGAN - June 27, 2025 ( NEWMEDIAWIRE ) - SeaStar Medical Holding Corp. (NASDAQ: ICU), the commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, has made a lot of inroads on that front with QUELIMMUNE. A humanitarian medical device, QUELIMMUNE treats pediatric patients with acute kidney injury or AKI due to sepsis or a septic condition. The QUELIMMUNE therapy received U.S. Food and Drug Administration approval in 2024 after clinical trials showed it could cut mortality in half from 50% to 25%.
DETROIT, MICHIGAN - June 27, 2025 ( NEWMEDIAWIRE ) - Dr. Kevin Chung, Chief Medical Officer at SeaStar Medical Holding Corporation (NASDAQ: ICU) and Dr. Stuart L. Goldstein, MD, from Cincinnati Children's Hospital Medical Center, were recently guests on Benzinga's All-Access.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
DETROIT, MICHIGAN - May 29, 2025 ( NEWMEDIAWIRE ) - SeaStar Medical Holding Corporation (NASDAQ: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, is seeing double-digit growth in sales of QUELIMMUNE, which drove revenues for the company in the first quarter of 2025.
DETROIT, MICHIGAN - May 21, 2025 ( NEWMEDIAWIRE ) - Eric Schlorff, CEO of SeaStar Medical Holding Corp. (NASDAQ: ICU), was recently a guest on Benzinga’s All-Access.
